The best AFib monitor depends on whether you want passive, around-the-clock screening or the most accurate on-demand recordings you can share with your doctor. For pure detection accuracy, the KardiaMobile 6L, a pocket-sized handheld device that records six leads of heart electrical activity, offers the highest clinical-grade performance available to consumers. For convenience and background monitoring, smartwatches from Apple, Samsung, Fitbit, and others can flag irregular rhythms automatically, then let you take a confirmatory ECG from your wrist.
Each type of device uses different technology, costs different amounts, and suits different situations. Here’s how they compare.
How Consumer AFib Monitors Work
Consumer monitors detect atrial fibrillation in two fundamentally different ways. Understanding the difference matters because it affects both accuracy and how you’ll use the device day to day.
The first method is called photoplethysmography, or PPG. This is the green light sensor on the back of a smartwatch. It shines light into your skin and measures tiny changes in blood flow to detect your pulse pattern. When the intervals between beats become irregular, the watch flags a possible arrhythmia. PPG works passively in the background, which is its biggest advantage: it can catch episodes you didn’t feel. The downside is that movement, a loose watchband, or even a hairy wrist can throw off readings.
The second method is a true ECG recording, which measures the electrical signals your heart produces. This requires you to touch electrodes with your fingers or press a device against your skin. Consumer ECG recordings typically last 30 seconds and produce a tracing your doctor can actually read, similar to what you’d get in a clinic. Many smartwatches now combine both methods: PPG runs in the background, and if something looks off, you can take a spot ECG to confirm.
KardiaMobile: Best Dedicated AFib Device
The KardiaMobile from AliveCor is the most widely studied handheld ECG monitor for consumers. The basic version is a credit-card-sized device with two metal electrodes. You place your fingers on it for 30 seconds, and it records a single-lead ECG that syncs to your phone. The algorithm then tells you whether your rhythm appears normal, shows possible atrial fibrillation, or is unclassified.
The upgraded KardiaMobile 6L records all six limb leads instead of just one. That distinction has real clinical value. In a head-to-head comparison, six-lead ECG detected AFib with 99.2% sensitivity compared to 95.7% for single-lead ECG. Six-lead recordings also produced far fewer false positives: only 1.6% of readings were incorrectly flagged as AFib, versus 7.5% for single-lead. The reason is straightforward. With six leads, one bad skin contact only corrupts two leads while leaving a third intact. With a single lead, one poor contact can make the entire recording unreadable. Single-lead devices were also four times more likely to return an inconclusive “cannot be concluded” result.
In clinical validation, the KardiaMobile 6L showed 86.4% sensitivity and 97.4% specificity for AFib when compared against a standard 12-lead hospital ECG. Those numbers are strong for a device that fits in your pocket. The REHEARSE-AF trial, which randomized over 1,000 people aged 65 and older, found that twice-weekly monitoring with a KardiaMobile device detected AFib in 3.8% of participants, compared to less than 1% who received standard care alone. That’s a meaningful difference for people at risk of undiagnosed AFib.
AliveCor offers an optional subscription called KardiaCare for $9.99 per month or $99 per year. It includes a board-certified cardiologist review of your ECG every 90 days, automatic ECG sharing with family members or caregivers, a monthly heart health summary report, and a care plan with reminders. The device itself works without the subscription, but these extras can be useful if you’re monitoring a known condition.
Apple Watch: Best for Passive Monitoring
The Apple Watch uses PPG to check your heart rate and rhythm at regular intervals throughout the day, measuring every minute while you’re still and every six seconds during workouts. If it detects an irregular rhythm, it sends a notification. You can then take an on-demand 30-second single-lead ECG by placing your finger on the watch crown.
A pooled analysis of multiple studies found the Apple Watch ECG detects AFib with 94.8% sensitivity and 95% specificity. The earlier Apple Heart Study, which looked specifically at the passive PPG-based irregular pulse notifications, reported a positive predictive value of 84%, meaning about 16% of alerts were false alarms. That’s a reasonable tradeoff for a device doing background screening on your wrist, but it does mean not every notification will turn out to be AFib.
The Apple Watch’s biggest strength is that it’s always on. You don’t have to remember to take a reading. If you have paroxysmal AFib (episodes that come and go), passive monitoring increases the odds of catching an episode during the minutes or hours it lasts. The tradeoff is that its single-lead ECG is less detailed than a six-lead device, and wrist-based readings are more prone to motion artifacts.
Fitbit, Samsung, and Other Smartwatches
Fitbit models like the Sense and Charge 5 can record a single-lead ECG and run background rhythm assessments using PPG. The Fitbit Heart Study reported a positive predictive value of 98.2% for irregular rhythm notifications, notably higher than the Apple Heart Study’s 84%. That suggests Fitbit’s algorithm may be more conservative, alerting you less often but with greater confidence when it does.
Samsung Galaxy Watch models (including the Galaxy Watch 3 and Galaxy Watch Active 2) and the Withings ScanWatch both offer PPG and ECG capabilities. The Garmin Venu 2 Plus also has ECG capability with FDA clearance for arrhythmia detection. All of these work on the same basic principle: passive PPG monitoring in the background with on-demand ECG recordings when you want a closer look.
If you already wear one of these watches, enabling the heart rhythm features is an easy, no-extra-cost way to screen for AFib. The accuracy differences between brands are relatively small, and all of them produce single-lead ECG tracings you can export and share with your doctor.
Smartphone Apps That Skip the Hardware
If you don’t want to buy a new device, smartphone camera apps can screen for AFib by analyzing your pulse through your fingertip. FibriCheck is the only smartphone app with FDA clearance for rhythm monitoring. A validation study found it detects AFib with 95.6% sensitivity and 96.6% specificity. A broader meta-analysis of several smartphone camera apps found a combined sensitivity of 94.2% and specificity of 95.8%.
These apps work by using your phone’s camera and flash to detect blood flow changes in your fingertip, similar to how a smartwatch PPG sensor works. They won’t produce an ECG tracing, so they’re a screening tool rather than a diagnostic one. If the app flags an irregular rhythm, you’d still want a proper ECG to confirm.
Single-Lead vs. Six-Lead: Why It Matters
The number of leads directly affects how well a device can distinguish true AFib from harmless extra beats. Premature atrial contractions (PACs) and premature ventricular contractions (PVCs), which are common and usually benign, can make your rhythm look irregular enough to fool a single-lead device. In testing, single-lead ECGs needed 3.4 times fewer extra beats before producing a false positive compared to six-lead ECGs. The six-lead device was the most robust tool because it could cross-check suspected irregularities across multiple electrical angles simultaneously.
This matters most if you already know you have frequent extra beats. In that scenario, a single-lead smartwatch ECG is more likely to give you an AFib alert that turns out to be nothing. A six-lead device like the KardiaMobile 6L will be more reliable at telling the difference.
What Causes Inconclusive Readings
Every consumer ECG device will occasionally return an “unreadable” or “inconclusive” result. The most common causes are practical, not medical. Dry skin, lotion, or oil on your fingertips can reduce the electrical signal. Hair under a wrist sensor weakens contact. Movement during the 30-second recording introduces noise that the algorithm can’t filter out. Cold hands can also affect readings because reduced blood flow to your fingertips weakens the signal.
To get the cleanest recordings, sit still, make sure your fingers are clean and dry, and press firmly on the electrodes for the full recording time. If you’re using a smartwatch, tighten the band so the sensor sits flush against your skin. Retake any inconclusive reading after waiting a minute or two.
Choosing the Right Monitor for You
Your best option depends on your situation:
- You’ve been diagnosed with AFib and want to track episodes: The KardiaMobile 6L gives you the most detailed, accurate recordings to share with your cardiologist. Its six-lead tracings provide information closer to what a clinical ECG delivers.
- You’re at risk and want screening while going about your day: A smartwatch with ECG capability (Apple Watch, Fitbit Sense, Samsung Galaxy Watch, or Withings ScanWatch) offers passive background monitoring that can catch episodes you don’t feel.
- You want occasional peace of mind without buying hardware: FibriCheck or another validated smartphone app lets you check your rhythm anytime using just your phone.
- You have frequent extra heartbeats: A six-lead device is worth the investment because it’s far less likely to confuse benign extra beats with AFib.
No consumer device replaces a clinical diagnosis. All FDA-cleared consumer monitors are intended for recording data to share with a healthcare provider, not for making treatment decisions on their own. What they do remarkably well is catch episodes of AFib that would otherwise go undetected between doctor visits, and that early detection is what makes them valuable.